Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TADLIQ safely and effectively. See full prescribing information for TADLIQ.TADLIQ® (tadalafil) oral suspensionInitial U.S. Approval: 2003
Medication labelWhy this: Advisory · dailymed-prescription
TADLIQ® is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II – III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%).
- generic_name
- tadalafil
- product_names
- Tadalafil
- ndc
- 46287-045, 46287-045-15
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en